The Effects of Post-Operative Interventions on Surgical Site Occurrences in AWR
Launched by OHIO STATE UNIVERSITY · May 24, 2021
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different types of dressings used after surgery can affect healing in patients who are having surgery for abdominal hernias. Specifically, it will compare three types of dressings: Prevena, Prineo, and traditional dressings. The goal is to see which dressing helps reduce the risk of complications at the surgical site.
To participate in this trial, you need to be over 18 years old and scheduled for elective surgery to repair a ventral hernia, which is a common type of abdominal hernia. You should be in good health overall, meaning you don’t have serious heart, lung, or kidney diseases. Importantly, you must be able to have your incision closed after surgery. If you join the trial, you will receive one of the three types of dressings after your surgery and will be monitored to see how well you heal. If you have any allergies to the materials used in these dressings or are a smoker, you may not be eligible to participate. This study is important as it could help improve recovery for future patients undergoing similar surgeries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \> 18
- • Patients presenting for elective ventral hernia repair
- • Patients deemed to be good surgical candidates, with no active life-threatening cardiac disease, pulmonary disease, renal disease, hematologic disease -Patients who will have a closed incision following the surgery
- Exclusion Criteria:
- • Known allergy to any material used in any wound treatment (Prevena- Acrylic adhesive or silver, Prineo- Dermabond glue, Standard- Bacitracin, Xeroform, surgical tape) -Active smokers (within the past 4 weeks) presenting for elective hernia repair
- • Patients with active life-threatening cardiac disease, pulmonary disease, renal disease, hematologic disease presenting for elective ventral hernia repair
- • Patients presenting for emergent ventral hernia repair (in the setting of bowel strangulation, necrosis, penetrating trauma) as it will be difficult to consent those patients for the study preoperatively
- • Patients with severe systemic sepsis
- • Patients with frank purulence in the wound -Patients with an open wound following surgery -Patients undergoing a panniculectomy
About Ohio State University
The Ohio State University (OSU) is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a commitment to improving patient care and outcomes, OSU leverages its extensive resources, interdisciplinary collaboration, and expertise in diverse medical fields. The university fosters an environment of rigorous scientific inquiry, ensuring that clinical trials are conducted with the highest ethical standards and adherence to regulatory guidelines. Through its Clinical Trials Office, OSU aims to translate groundbreaking research into practical applications, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbus, Ohio, United States
Patients applied
Trial Officials
Jeffrey E Janis, MD
Principal Investigator
Ohio State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials